Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma
- 1 August 2014
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 134 (2) , 287-294.e5
- https://doi.org/10.1016/j.jaci.2014.04.005
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trialThe Lancet, 2012
- Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe AsthmaJournal of Allergy and Clinical Immunology, 2010
- Mepolizumab and Exacerbations of Refractory Eosinophilic AsthmaNew England Journal of Medicine, 2009
- Mepolizumab for Prednisone-Dependent Asthma with Sputum EosinophiliaNew England Journal of Medicine, 2009
- Cluster Analysis and Clinical Asthma PhenotypesAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Severe asthma in adults: What are the important questions?Journal of Allergy and Clinical Immunology, 2007
- Determining asthma treatment by monitoring sputum cell counts: effect on exacerbationsEuropean Respiratory Journal, 2006
- Asthma exacerbations and sputum eosinophil counts: a randomised controlled trialThe Lancet, 2002
- Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthmaClinical and Experimental Allergy, 2002
- The costs of asthmaEuropean Respiratory Journal, 1996